ICC Melanoma Application icon

ICC Melanoma 1.1.3

11.3 MB / 0+ Downloads / Rating 5.0 - 1 reviews


See previous versions

ICC Melanoma, developed and published by Forum Service s.r.l., has released its latest version, 1.1.3, on 2020-09-25. This app falls under the Education category on the Google Play Store and has achieved over 10 installs. It currently holds an overall rating of 5.0, based on 1 reviews.

ICC Melanoma APK available on this page is compatible with all Android devices that meet the required specifications (Android 4.1+). It can also be installed on PC and Mac using an Android emulator such as Bluestacks, LDPlayer, and others.

Read More

App Screenshot

App Screenshot

App Details

Package name: com.forumservicesrl.iccmelanoma

Updated: 4 years ago

Developer Name: Forum Service s.r.l.

Category: Education

New features: Show more

App Permissions: Show more

Installation Instructions

This article outlines two straightforward methods for installing ICC Melanoma on PC Windows and Mac.

Using BlueStacks

  1. Download the APK/XAPK file from this page.
  2. Install BlueStacks by visiting http://bluestacks.com.
  3. Open the APK/XAPK file by double-clicking it. This action will launch BlueStacks and begin the application's installation. If the APK file does not automatically open with BlueStacks, right-click on it and select 'Open with...', then navigate to BlueStacks. Alternatively, you can drag-and-drop the APK file onto the BlueStacks home screen.
  4. Wait a few seconds for the installation to complete. Once done, the installed app will appear on the BlueStacks home screen. Click its icon to start using the application.

Using LDPlayer

  1. Download and install LDPlayer from https://www.ldplayer.net.
  2. Drag the APK/XAPK file directly into LDPlayer.

If you have any questions, please don't hesitate to contact us.

Previous Versions

ICC Melanoma 1.1.3
2020-09-25 / 11.3 MB / Android 4.1+

About this app

COME GESTIRE LA TOSSICITÀ E VALUTARE LA RISPOSTA ALL’IMMUNOTERAPIA NEI PAZIENTI CON MELANOMA

La terapia immunologica del melanoma sta attraversando una fase di grande evoluzione, grazie agli importanti risultati ottenuti in molti studi clinici, a partire dal 2010, a seguito dell’introduzione degli anticorpi diretti contro i checkpoint immunologici come CTLA-4 e, in particolare, PD-1. Lo scopo di questo progetto è di approfondire i principali scenari di difficile gestione del paziente affetto da melanoma in terapia con anticorpi ant-PD-1, attraverso esempi di situazioni cliniche interattive.

New features

Corretto bug su autenticazione utente

App Permissions

Allows applications to open network sockets.